Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

In the era of precision medicine, research of biomarkers for identification of responders to nivolumab therapy is a major challenge. Peripheral blood mononuclear cells (PBMC) could be an interesting surrogate tissue for identifying pharmacodynamic biomarkers. The aim of this exploratory study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Noé, Gaëlle, Bellesoeur, Audrey, Golmard, Lisa, Thomas-Schoemann, Audrey, Boudou-Rouquette, Pascaline, Tiako Meyo, Manuela, Puszkiel, Alicja, Arrondeau, Jennifer, Alexandre, Jérome, Goldwasser, François, Blanchet, Benoit, Vidal, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628172/
https://www.ncbi.nlm.nih.gov/pubmed/31159331
http://dx.doi.org/10.3390/cancers11060762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628172/
https://www.ncbi.nlm.nih.gov/pubmed/31159331
http://dx.doi.org/10.3390/cancers11060762

Ejemplares similares